Poor Ovarian Reserve: Evaluation and Counselling

CASE DISCUSSION

Poor Ovarian Reserve: Evaluation and Counselling

Presented from by Dr. Lavanya Kiran

Views

159

Case Description

This webinar will focus on the clinical approach to diagnosing Poor Ovarian Reserve (POR) using key markers such as AMH, antral follicle count (AFC), and basal FSH levels. It will discuss evidence-based strategies for assessing ovarian reserve and differentiating diminished reserve from normal...

Case Summary

  • Poor ovarian reserve (POR) signifies a reduced number of oocytes and follicles, decreasing conception chances. Evaluation is crucial for tailored treatment, impacting IVF cycle success rates, which can be as low as 5-15%. The incidence of POR is rising, affecting a significant portion of IVF cycles and leading to frequent cycle cancellations.

Speaker Profile

Dr. Lavanya Kiran

Dr. Lavanya Kiran

Director and Consultant at KIMS Hospital, Bangalore. Clinical Director at Lakshya Fertility Centre, Bangalore and Founder Chairperson & Medical Director at Orya Care
Dr. Kiran is a highly accomplished Obstetrician and Gynecologist with advanced expertise in Reproductive Medicine, Regenerative Medicine, and Cosmetic Gynecology. After completing her MBBS from M.S. Ramaiah Medical College and MS (OBG) from Kempegowda Institute of Medical Sciences, she pursued specialized training in Reproductive Medicine in Germany and at Rajiv Gandhi University, along with fellowships from IASRM. She further strengthened her academic and administrative credentials with an MBA in Hospital Management and a PG Diploma in Medical Law and Ethics from the National Law School of India University. Currently, she serves as Director and Consultant at KIMS Hospital, Clinical Director at Lakshya Fertility Centre, and Founder Chairperson & Medical Director at Orya Care, where she integrates advanced fertility care with innovative regenerative and robotic techniques.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.